TY - CHAP
T1 - Anxiety in Parkinson's Disease
AU - Simuni, Tanya
AU - Fernandez, Hubert H.
PY - 2013
Y1 - 2013
N2 - Anxiety is a common neuropsychiatric manifestation of PD that has a significant impact on disease-related QOL. There is a remarkable paucity of organized data on the choice of pharmacological management of anxiety in PD. Well-designed studies are necessary. However, based on clinical experience, the agents that are effective in management of the primary anxiety disorders also appear to be efficacious in PD-related anxiety.
AB - Anxiety is a common neuropsychiatric manifestation of PD that has a significant impact on disease-related QOL. There is a remarkable paucity of organized data on the choice of pharmacological management of anxiety in PD. Well-designed studies are necessary. However, based on clinical experience, the agents that are effective in management of the primary anxiety disorders also appear to be efficacious in PD-related anxiety.
KW - Agoraphobia
KW - Anxiety disorders
KW - Anxiety disorders in PD
KW - Anxiety status inventory
KW - Beck anxiety inventory
KW - Hamilton anxiety rating scale
KW - Hospital anxiety and depression scale
KW - Spielberger state trait anxiety inventory
KW - Zung self-rating anxiety scale
UR - http://www.scopus.com/inward/record.url?scp=84899671402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899671402&partnerID=8YFLogxK
U2 - 10.1007/978-1-60761-429-6_2
DO - 10.1007/978-1-60761-429-6_2
M3 - Chapter
AN - SCOPUS:84899671402
SN - 9781607614289
T3 - Current Clinical Neurology
SP - 17
EP - 29
BT - Parkinson's Disease and Nonmotor Dysfunction
PB - Humana Press Inc.
ER -